# Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women

> **NCT01652313** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 12 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Rasagiline

## Key facts

- **NCT ID:** NCT01652313
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-06
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01652313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01652313, "Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01652313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*